Interested in a demo of the CareGLP platform?
Pump up your gym’s potential with CareGLP! Our GLP-1 program is the ultimate fitness companion, supercharging your clients’ health journeys from the inside out.
Pump up your gym’s potential with CareGLP! Our GLP-1 program is the ultimate fitness companion, supercharging your clients’ health journeys from the inside out.
As a gym or fitness studio owner, you’re dedicated to helping your members achieve their health and fitness goals. By offering GLP-1 therapies through CareGLP, you can provide a powerful new tool for members struggling with weight management, complementing their fitness routines with a clinically-backed solution. CareGLP makes it easy to integrate these therapies into your offerings, managing everything from member onboarding to delivery, so you can focus on what you do best—helping your clients stay fit and healthy.
See how leading gyms and fitness studios have revolutionized their offerings with CareGLP. Meet some of our distinguished partners:
Whether you run a boutique fitness studio or a large gym, this tool will help you visualize the substantial revenue opportunities that come with integrating CareGLP. Explore your potential for increased earnings!
Monthly Profit: $0
Yearly Profit: $0
Note: Actual revenue can vary and is dependent on items such as medication costs, dosages, telehealth visit and others
Transform Your Fitness Studio With a Holistic Path to Better Health and Fitness.
Get setup with your brandable patient intake and portal for a frictionless care journey from first touchpoint to treatment
Start utilizing the CareGLP platform for patient intake, side effect tracking, clinician network consultations and the entire workflow to deliver GLP-1’s directly to your populations
By offering GLP1 drugs via our telehealth offering.
Looking to boost your studio’s growth? Our targeted GLP-1 digital marketing strategy can dramatically increase your patient base. Enhance your visibility and attract clients who are specifically seeking GLP-1 treatments.